Galvus 50mg provides vildagliptin 50mg, an oral DPP-4 inhibitor. By inhibiting the DPP-4 enzyme, vildagliptin increases the availability of incretin hormones, helping enhance insulin secretion when glucose levels are elevated and reduce inappropriate glucagon release.

Its glucose-dependent mechanism provides a distinct approach from medicines such as metformin and sulfonylureas. Galvus may be prescribed alone or in combination with other antidiabetic medicines depending on the treatment plan.

Brand: Galvus

Active Ingredient: Vildagliptin

Strength: 50mg

Form: Tablet

Pack: 15 tablets

Drug Class: DPP-4 inhibitor

The appropriate regimen should be determined according to the patient’s clinical requirements.